Literature DB >> 16872784

Application of an oligonucleotide array assay for rapid detecting and genotyping of Chlamydia trachomatis from urogenital specimens.

He-ping Zheng1, Li-fang Jiang, Dan-yun Fang, Yao-hua Xue, Ya-an Wu, Jin-mei Huang, Zhi-ying Ou.   

Abstract

An oligonucleotide array technology was established for rapidly detecting and genotyping Chlamydia trachomatis in urogenital infections. The VS1-VS2 region of the omp1 gene was used to design oligonucleotide probes. Eleven serovar-specific probes to serovars A, B, C, D, E, F, G, H, I, J, and K, and 3 group-specific probes to group B (B, Ba, D, E, L1, and L2), group C (A, C, H, I, J, K, and L3), and an intermediate group (F and G) were synthesized and spotted onto the nylon membrane. Two pairs of universal primers were designed for the nested polymerase chain reaction (PCR) amplification of the VS1-VS2 gene. Digoxigenin-labeled amplicons of the VS1-VS2 gene of C. trachomatis were hybridized to the membrane array. Hybridization signals were read by the nitroblue tetrazolium/5-bromo-4-chloro-3-indolylphosphate color development. The assay developed was tested with reference strains of C. trachomatis serovars and clinical samples. The sensitivity was evaluated for 57 samples previously found to be positive for C. trachomatis by using plasmid PCR, and 98.2% (56/57) concordance was obtained. Fourteen oligonucleotide probes were optimized by trying different reaction conditions, showing specific hybridization with the corresponding reference strains, but no cross-reactions with other urogenital microorganisms. Using this procedure, a total of 59 strains were detected from 56 chlamydial samples. Eight genotypes were found, and type D, E, F, and H were the most frequently observed types (77.9%). Three cases (5.4%) had multiple infections with serovars: 1.D/E, 2.D/F, and 3.F/K. To validate the reference strains and confirm the genotype identity as determined by the oligonucleotide array technology, we sequenced all reference strains and 10 selected specimens across variable sequence VS1 and VS2. No discrepancies were found between the array typing and the genotype identity confirmed by nucleotide sequencing of the PCR product. The findings from this study indicated that the oligonucleotide array is a simple, fast, and specific assay for directly detecting and genotyping C. trachomatis from clinical samples.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16872784     DOI: 10.1016/j.diagmicrobio.2006.05.007

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  9 in total

1.  Development and evaluation of an ompA quantitative real-time PCR assay for Chlamydia trachomatis serovar determination.

Authors:  Matthew P Stevens; Jimmy Twin; Christopher K Fairley; Basil Donovan; Sarah E Tan; Jingxi Yu; Suzanne M Garland; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

2.  Evaluation of a novel Chlamydia trachomatis microsphere suspension assay for detection and genotyping of the different serovars in clinical samples.

Authors:  Koen D Quint; Daan T Geraets; Henk A M van den Munckhof; Maurits N C de Koning; Vitaly Smelov; Willem J G Melchers; Henry J C de Vries; Servaas A Morré; Chris J M Meijer; Dirk C J G van Alewijk; Leen-Jan van Doorn; Wim G V Quint
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

3.  Genotyping of Chlamydia trachomatis by microsphere suspension array.

Authors:  Chung-Ter Huang; Wing-Wai Wong; Lan-Hui Li; Chien-Chou Chiang; Bor-Dong Chen; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2008-01-03       Impact factor: 5.948

4.  Development of real-time PCR assays for genotyping of Chlamydia trachomatis.

Authors:  Hamid Jalal; Hannah Stephen; Sarah Alexander; Christopher Carne; Christopher Sonnex
Journal:  J Clin Microbiol       Date:  2007-06-13       Impact factor: 5.948

5.  Chlamydia trachomatis from Australian Aboriginal people with trachoma are polyphyletic composed of multiple distinctive lineages.

Authors:  Patiyan Andersson; Simon R Harris; Helena M B Seth Smith; James Hadfield; Colette O'Neill; Lesley T Cutcliffe; Fiona P Douglas; L Valerie Asche; John D Mathews; Susan I Hutton; Derek S Sarovich; Steven Y C Tong; Ian N Clarke; Nicholas R Thomson; Philip M Giffard
Journal:  Nat Commun       Date:  2016-02-25       Impact factor: 14.919

6.  Prevalence and genotyping of Chlamydia trachomatis in symptomatic male patients from Istanbul, Turkey.

Authors:  Muammer Osman Köksal; Hayati Beka; Mehmet Demirci; Ates Kadioglu; Ali Agacfidan; Baki Akgül
Journal:  Springerplus       Date:  2016-10-04

7.  Comparison of reverse hybridization and ompA sequencing methods applied on Chlamydia trachomatis strains from Tunisia.

Authors:  Houda Gharsallah; Olfa Frikha-Gargouri; Reinier J Bom; Adnene Hammami; Sylvia M Bruisten
Journal:  Microbiologyopen       Date:  2017-12-28       Impact factor: 3.139

8.  Chlamydia trachomatis genovar distribution in clinical urogenital specimens from Tunisian patients: high prevalence of C. trachomatis genovar E and mixed infections.

Authors:  Houda Gharsallah; Olfa Frikha-Gargouri; Hanen Sellami; Fatma Besbes; Abir Znazen; Adnene Hammami
Journal:  BMC Infect Dis       Date:  2012-11-30       Impact factor: 3.090

9.  Rapid detection of Chlamydia trachomatis and typing of the Lymphogranuloma venereum associated L-Serovars by TaqMan PCR.

Authors:  Anke Schaeffer; Birgit Henrich
Journal:  BMC Infect Dis       Date:  2008-04-30       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.